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Abstract
Cranberry-derived compounds, including a fraction known as proanthocyanidins (PACs) exhibit anti-microbial, anti-infective,
and anti-adhesive properties against a number of disease-causing organisms. In this study, the effect of cranberry
proanthocyanidins (CPACs) on the infection of epithelial cells by two enteric bacterial pathogens, enteropathogenic
Escherichia coli (EPEC) and Salmonella Typhimurium was investigated. Immunofluorescence data showed that actin pedestal
formation, required for infection by enteropathogenic Escherichia coli (EPEC), was disrupted in the presence of CPACs. In
addition, invasion of HeLa cells by Salmonella Typhimurium was significantly reduced, as verified by gentamicin protection
assay and immunofluorescence. CPACs had no effect on bacterial growth, nor any detectable effect on the production of
bacterial effector proteins of the type III secretion system. Furthermore, CPACs did not affect the viability of host cells.
Interestingly, we found that CPACs had a potent and dose-dependent effect on the host cell cytoskeleton that was evident
even in uninfected cells. CPACs inhibited the phagocytosis of inert particles by a macrophage cell line, providing further
evidence that actin-mediated host cell functions are disrupted in the presence of cranberry CPACs. Thus, although CPAC
treatment inhibited Salmonella invasion and EPEC pedestal formation, our results suggest that this is likely primarily because
of the perturbation of the host cell cytoskeleton by CPACs rather than an effect on bacterial virulence itself. These findings
have significant implications for the interpretation of experiments on the effects of CPACs on bacteria-host cell interactions.
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Introduction
The consumption of cranberry has been linked with the
prevention and treatment of urinary tract infections for over 100
years. However, a mechanistic understanding of the way in which
cranberry materials prevent bacterial infection is still lacking.
Some studies suggest that a specific fraction of the cranberry
known as proanthocyanidins (PACs) is responsible for its anti-
infective properties [1,2,3,4].
PACs are part of a group of chemicals known as flavonoids and
can be found in many other fruits, seeds, leaves and nuts. In
addition to PAC, flavonoid compounds include anthocyanins,
flavonols and catechins and are often collectively referred to as
‘‘extracts’’ [5]. At certain concentrations, cranberry flavonoids
have been attributed antiviral properties [6,7] as well as
antimicrobial properties against many important human patho-
gens, including Escherichia coli, Helicobacter pylori, Listeria monocyto-
genes, Porphyromonas gingivalis, Salmonella Typhimurium, and Staph-
ylococcus aureus [8,9,10,11,12,13]. In addition to these observed
antiviral and antibacterial properties, cranberry flavonoids also
exhibit effects directly on mammalian cells. Specifically, they have
been associated with the induction of apoptosis of adenocarcinoma
cells [14,15,16,17], have exhibited anti-inflammatory activity
[15,18] and have been shown to act as a cardiovascular protector
[19,20]. Increasingly, PACs are believed to be the subgroup of
flavonoids responsible for these effects.
Cranberry PACs (CPACs) have been linked with a reduction in
bacterial adhesion onto biological [2,3,21,22,23,24] and non-
biological [25,26] surfaces. Proposed mechanisms of action include
CPACs’ potent antioxidant capacity [27,28], metal chelation
[29,30], blocking motility [31,32] or by simple steric interference
between bacteria and a target surface [25]. Few studies, however,
have examined the impact of CPACs directly on host cells, during
their interaction with pathogenic bacteria.
CPACs are high molecular weight compounds made up of
flavan-3-ol monomers [2]. While still open for debate, it is believed
that lower-order polymers are absorbed into the bloodstream
subsequent to ingestion, leaving higher-order polymers intact in
the gastrointestinal (GI) tract [5,33]. If higher-order CPACs are
not metabolized, it becomes of interest to study the effect of
CPACs on GI health. Therefore, since CPACs may be present in
the GI tract, and have the potential to act on GI pathogens
directly and to affect their adhesion to surfaces, we decided to
characterize the interaction of gut pathogens with host cells in the
presence of CPAC.
Two important gut pathogens were chosen as models for enteric
infection. Enteropathogenic Escherichia coli (EPEC) is a major cause
of infantile diarrhoea [34] while Salmonella Typhimurium is one of
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study to examine the role of CPACs in EPEC and Salmonella
infection. Our results demonstrate that CPACs protect epithelial
cells from infection by these two important gut pathogens.
Furthermore, we provide evidence that the protection observed
is not due to an antimicrobial or anti-infective effect of CPACs on
the bacteria, but rather results from alterations of the host cell
cytoskeleton in the presence of CPACs. These findings have
important implications for studies on the effect of CPACs and
related compounds on host-pathogen interactions.
Results
A fundamental characteristic of EPEC infection of host cells is
the formation of actin pedestal structures located directly beneath
adherent bacteria [36,37]. Pedestal formation requires the type III
secretion system mediated translocation of a bacterial protein, Tir,
into the host cell membrane. Tir has an intracellular domain that
mediates the polymerization of host cell actin at the site of
bacterial attachment [38]. To assess the effect of CPACs on the
interaction of EPEC with host cells, we examined pedestal
formation in the presence and absence of a purified CPAC
preparation. In cells infected with EPEC but untreated with
CPACs, robust actin polymerization was evident at the site of
bacterial attachment (Figure 1, white arrows, top panels).
However, localized actin polymerization was greatly diminished
in the presence of CPACs (Figure 1, white arrows, bottom panels).
Although CPACs had no effect on bacterial growth at all
concentrations tested (see below), the number of adherent EPEC
bacteria was also significantly reduced in the CPAC treated
sample (Figure 1, left panels). Analysis of CLSM images of HeLa
cells revealed that 9.5%60.3 of the cell surface area was covered
with EPEC under control conditions, but only 2.7%60.8 of the
cell surface area was covered with EPEC when the cells had been
exposed to CPACs. CPACs also exerted similar effects during
infection of HeLa cells with RDEC-1, a rabbit pathogen closely
related to EPEC (Figure S1).
Whereas EPEC is an intestinal pathogen that is able to infect
from an extracellular position, Salmonella Typhimurium invades
epithelial cells and replicates intracellularly [39]. To assess the
effect of CPACs on the interaction of an invasive intestinal
pathogen with epithelial cells, we performed two independent S.
Typhimurium invasion assays in the presence and absence of
CPACs, using the S. Typhimurium Keller strain. A gentamicin
protection assay was used to enumerate internalized bacteria
(Figure 2a), while immunofluorescence was used to visualize the
cells and bacteria (Figure 2b–e). The gentamicin protection assay
revealed a potent and dose-dependent inhibition of Salmonella
invasion by CPACs with a 10-fold reduction at the lowest
concentration tested (25 mg/mL) and over a 100 000-fold
reduction in invaded bacteria at 100 mg/mL. This effect was
confirmed in the immunofluorescence images. In the latter assay,
bacteria that have invaded the HeLa cell are shown in red,
whereas S. Typhimurium cells that remain outside the host cell are
stained green. Figure 2b shows that a large number of bacteria are
able to invade the HeLa cells under control conditions. In contrast,
Figure 2e reveals that nearly no bacteria in the field have been
internalized in the presence of CPACs. These results show that
CPACs strongly inhibit S. Typhimurium invasion into HeLa cells
(Figure 2). CPACs also potently decreased the host cell invasion of
two additional Salmonella Typhimurium strains, as shown by the
gentamicin protection assay (Figure S2).
After observing these changes in infection levels, we examined
whether CPAC treatment was affecting the growth of EPEC and
Salmonella. Growth curves were performed over 8 hours on both
bacterial species in the absence and presence of increasing
Figure 1. EPEC pedestal formation in the presence of CPAC. HeLa cells infected for 6 hours with EPEC. Left panel is EPEC-GFP (green), actin
staining in the centre panel (red) and a colour overlay on the right. Control experiment (top panels) demonstrates the presence of actin pedestals
beneath bacteria (top arrows). In the presence of 100 mg/mL CPAC (bottom panels), localization of actin beneath EPEC bacteria is disrupted (bottom
arrows). An overall change in the number of adhered bacteria as well as a change in HeLa cell morphology is also observed. Experiments were carried
out in triplicate and a single representative image set was used for each condition. Scale bar indicates 25 mm.
doi:10.1371/journal.pone.0027267.g001
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EPEC or Salmonella at CPAC concentrations of 100 mg/mL
(Figure 3a). We next assessed whether CPACs were acting as
inhibitors of bacterial type III secretion. Type III secretion systems
are important virulence determinants of a number of gram-
negative pathogens, including EPEC and S. Typhimurium. They
act by translocating bacterial effector proteins into host cells to
subvert host cell functions to favour bacterial replication or
survival. Type III secretion is required for both EPEC pedestal
formation and S. Typhimurium invasion [38,39]. Furthermore, it
has previously been reported that bacterial type III secretion is
inhibited by flavonoids from citrus fruit [40,41]. Assays have been
developed to assess type III effector secretion into growth medium
in the absence of host cells. In these assays, bacteria are grown in
secretion-inducing medium and effector-containing supernatants
are collected following removal of the bacterial cells by
centrifugation. Initially, we observed an absence of type III
secreted effector proteins in the supernatants in the presence of
CPACs (data not shown). However, further experimentation
revealed that addition of CPACs to secreted protein fractions
prepared in the absence of CPACs also lead to their precipitation
and removal from the supernatant upon centrifugation (Figure 3b).
This is consistent with a previous report that CPACs can
precipitate proteins [42]. Indeed, we found that the secreted
proteins were present in the pellets of the CPAC-treated samples
after centrifugation (Figure 3b). Thus, precipitation of proteins by
CPACs makes assessment of the effect of CPACs on type III
secretion unfeasible. Due to this technical limitation, we assessed
the production (rather than secretion) of type III-secreted effector
proteins by EPEC, using Western blotting of total bacterial
extracts, and found that they had no effect (Figure 3b, wells 1–4).
Based on these results we hypothesized that the anti-infective
properties of CPACs noted here may be linked to effects on the
host cell.
A common element between EPEC pedestal formation and
Salmonella Typhimurium invasion into host cells is the requirement
for specific bacterially-induced rearrangements of the host cell
actin cytoskeleton. We noted that the actin staining in the
micrographs of EPEC infected cells appeared very different in the
CPAC treated and untreated cells (Figure 1, middle panels). To
test whether CPACs could affect the actin cytoskeleton in the
absence of infection, we treated uninfected HeLa cells with
increasing concentrations of CPACs for a duration of 4 hours and
then stained the cells for polymerized actin and for several
cytoskeleton-associated proteins. The images show that CPAC
treatment alone leads to a perturbation of the cytoskeleton in a
dose-dependent manner (Figure 4). Changes in polymerized actin,
cell shape and size, and localization of focal adhesion proteins
(VASP) were evident even with the lowest concentration of CPACs
examined (25 mg/mL). At 50 mg/mL CPACs, most of the VASP
protein no longer localized at the focal adhesions and the shape of
the cell was markedly changed. At 100 mg/mL, CPACs had the
most dramatic effect on cell shape, size, and protein localization.
Two other actin cytoskeleton-associated proteins tested (a-actinin
and paxillin) also demonstrated the same type of delocalization
similar to that noted for VASP in Figure 4 (data not shown). To
verify whether the notable reorganization of the cytoskeleton led to
damage of the HeLa cells, we conducted a viability assay in the
presence and absence of CPACs. HeLa cells were treated with
CPACs for 4 hours and viability was determined using a
commercial staining kit which differentiates dead cells according
to their permeability to ethidium homodimer-1. No significant
change in viability was observed for CPACs concentrations
ranging from 0–100 mg/mL (Figure 5). We observed a slight
increase in the number of dead cells in the presence of 200 mg/mL
CPAC, though this result was not found to be statistically
significant.
Though HeLa cell viability was unaffected, we hypothesized
that the cytoskeletal changes induced by CPACs would lead to a
disruption of normal cytoskeletal function. To test this hypothesis
in a non-infection model, and to verify whether the effects of
CPACs were generalizable to multiple cell types, we studied the
phagocytosis of inert model particles by J774 murine macrophage
cells. Like EPEC pedestal formation and Salmonella invasion,
phagocytosis requires extensive remodelling of the actin cytoskel-
eton. To assess phagocytosis, we used BioParticles which fluoresce
only when exposed to the acidic pH of the phagosomal
Figure 2. Invasion of HeLa cells by Salmonella Typhimurium.
HeLa cells infected with S. Typhimurium for 40 minutes were
enumerated (panel a) or visualized by immunofluorescence (IF, panels
b–e). IF staining was performed such that internalized bacteria is
represented in red and external bacteria is represented in green. S.
Typhimurium readily invades cells when no CPAC is present at a
frequency of about 1 bacterium per HeLa cell (see panel a and b). In the
presence of 25 mg/mL CPAC (panel c), this frequency is diminished by
roughly 90%. Panels d and e represent a CPAC concentration of 50 and
100 mg/mL respectively and near negligible amounts of invasion was
observed. Scale bar indicates 25 mm. Error bars on graph represent one
standard deviation. Experiments were carried out separately, in
triplicate, and a single representative sample was chosen for each
concentration.
doi:10.1371/journal.pone.0027267.g002
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control conditions (no CPACs), BioParticles were readily taken up
by macrophage cells and fluoresced brightly. However, in the
presence of CPACs, uptake of BioParticles by murine macro-
phages was reduced significantly and in a dose-dependent manner
(Figure 6). To ensure that the decrease in fluorescence correlated
with decreased phagocytosis of the particles, samples were also
examined by fluorescent microscopy and decreased phagocytosis
of particles in the presence of CPACs was observed (data not
shown).
Figure 3. Bacterial growth and secretion of EPEC in the presence of CPAC. Growth of EPEC and S. Typhimurium in the presence of 0 and
100 mg/mL CPAC was examined over 8 hours. CPAC had no effect on the growth of both bacterial strains (Figure 3a). EPEC total proteins were
resolved by 12% SDS-PAGE in the presence of increasing amounts of CPAC before probing for Tir protein on Western Blot (wells 1–4); 0, 25, 50,
100 mg/mL CPAC respectively). EPEC secreted proteins after 30 min incubation with 0, 25, 50, 100 mg/mL CPAC (supernatant, wells 5–8 respectively;
pellet, wells 9–12 respectively). CPAC had no effect on the production of effector proteins, but readily precipitates proteins (Figure 3b).
doi:10.1371/journal.pone.0027267.g003
Figure 4. Assessment of the effect of CPAC on the host cell cytoskeleton. HeLa cells were exposed to three concentrations of CPAC for
4 hours before using immunofluorescence to visualize cell structure. Cells were stained for actin (red, left), for vasodilator-stimulated phosphoprotein
(VASP, green, second column), and DAPI (blue, third column). A colour composite image is shown in the right column. Control experiments (top
panels) demonstrate normal actin arrangement as well as localization of VASP protein to the focal adhesion points. In a dose-dependent manner,
actin arrangement is disrupted, in parallel with the delocalization of the VASP protein from the focal adhesion points as established by the second
(25 mg/mL CPAC), third (50 mg/mL CPAC) and fourth (100 mg/mL CPAC) rows. The effect on the actin cytoskeleton is similar to the effect seen in
Figure 1. Scale bars indicate 25 mm.
doi:10.1371/journal.pone.0027267.g004
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In this work, we studied the effect of CPACs on infection of cells
with two important gastrointestinal pathogens, EPEC and
Salmonella Typhimurium. CPACs inhibited EPEC attachment to
cells (Figure 1) and prevented actin pedestal formation by EPEC, a
process thought to be of critical importance for the establishment
of a productive EPEC infection. CPACs also markedly reduced
infection of epithelial cells by Salmonella Typhimurium (Figure 2).
Notably, Salmonella was incapable of invading host cells even at
relatively low concentrations of CPACs (10-fold reduction at
25 mg/mL). This suggests that CPACs can possibly prevent enteric
infections in the body, though further in vivo studies regarding the
bioavailability of CPACs are required.
While still open for debate, it is believed that lower-order CPAC
polymers are absorbed into the bloodstream subsequent to
ingestion, leaving higher-order polymers intact in the GI tract
where they could potentially act on GI bacteria [5,33]. To date, a
clear link between diets high in PAC-containing foods and reduced
GI infection has not been established, but the current findings
indicate that further study may be warranted.
EPEC pedestal formation and Salmonella host cell invasion
require viable bacteria and the translocation of bacterial effector
proteins into host cells via the bacterial type III secretion system.
An attempt was made to determine the effect of CPACs directly on
bacteria. Though other studies have demonstrated the use of
cranberry compounds as an antimicrobial agent [8,9,10,11,12,13],
there is no evidence to support this in the current study (Figure 3a).
This may be due to the CPAC concentrations tested here. In
addition, although other groups have reported that other fruit
flavonoids can inhibit production of type III secreted proteins
[40,41], we found that CPACs had no direct effect on the
expression of EPEC effector proteins under the conditions we
employed (Figure 3b). Although not tested, it is likely that the
expression of Salmonella effector proteins was also unaffected by
CPACs because of the similarity of the two type III secretion
systems. Though no measurable effect was observed on bacterial
growth or effector protein levels, we cannot exclude the possibility
that CPACs did have other effects on the bacterial cells that were
not assessed here. However, our finding that CPACs had a
dramatic and dose-dependent effect on the host epithelial cell
cytoskeleton (Figure 4), offers a probable explanation for one of the
key CPAC anti-infective mechanisms. In order to infect the host
cell, EPEC and Salmonella rely on the hijacking of cellular
machinery, and in particular, they manipulate the host actin
cytoskeleton [38,39]. We hypothesized that the actin cytoskeleton
alterations induced by CPACs rendered the cytoskeleton resistant
to the bacterially-induced remodelling normally directed by type
III-translocated effector proteins. We predicted that if this were
true, CPAC treatment would also render the actin cytoskeleton
resistant to non-bacterially-induced actin remodelling. To test this,
we examined the phagocytosis of non-living particles in the
presence or absence of CPACs. Professional phagocytic cells such
as macrophages engulf foreign particles through the process of
phagocytosis. The process requires extensive remodelling of the
actin cytoskeleton and is sensitive to inhibitors of actin polymer-
ization. The uptake of these model particles was dramatically
reduced in the presence of CPACs (Figure 6).
One caveat of the work presented here is that these studies were
performed in HeLa cells and a mouse macrophage cell line. While
HeLa cells are a commonly used and widely accepted model cell
line to assess both EPEC pedestal formation and Salmonella
invasion, they do not accurately model all aspects of the polarized
epithelia of the GI tract. It will be of interest to extend our findings
in polarized intestinal epithelial cell lines and in in vivo infection
models. Notably, we have observed striking changes in the actin
cytoskeleton of the polarized intestinal epithelial cell line Caco-2
upon CPACs treatment (data not shown), and current efforts in
our labs include further characterizing these effects.
The mechanism by which CPACs induce perturbation of the
actin cytoskeleton is not known, but ongoing work in our
laboratory aims to address this question. Other flavonoids have
been shown to affect the actin cytoskeleton, but the mechanisms by
Figure 5. Viability of HeLa cells. HeLa cells were treated with
varying concentration of CPAC for 4 hours before determining viability
using a viability/cytotoxicity kit and fluorescence imaging. CPAC had no
effect on the viability of epithelial cells after 4 hours and at the
concentrations tested. Error bars represent one standard deviation from
the analysis of a minimum of six photos per concentration.
doi:10.1371/journal.pone.0027267.g005
Figure 6. Phagocytosis of fluorescent BioParticles. Particles
conjugated to a pH-sensitive fluorophore will fluoresce subsequent to
internalization by a macrophage cell. In the presence of 50 mg/mL
CPAC, fluorescence is reduced three-fold, indicating that the phagocy-
tosis of these particles was reduced. In the presence of 100 mg/mL, this
was reduced six-fold compared to the control. Error bars represent one
standard deviation from one experiment performed in triplicate.
doi:10.1371/journal.pone.0027267.g006
Cranberry Proanthocyanidins and Enteric Infections
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27267which they do so are not well characterized [43,44]. Indeed, PACs
from many other fruits, berries, barks and seeds have been
attributed related properties as was recently reviewed by de la
Iglesia et al. [27]. Many studies, however, have pointed to the fact
that cranberries contain PACs with A-type linkages that may have
different properties than the more common B-type PAC [27,45].
Therefore, it is unclear whether grape seed PACs, for example,
will have the same effect as CPACs, as in the current study. As
purification techniques improve and these types of compounds are
isolated further into dimers, trimers etc. extensive testing should be
carried out and the results can be compared across PACs from
several species. In addition to this, the bioavailability of these
groups of compounds needs to be studied further, as very little is
known about the fate of these compounds after ingestion [33]. To
date, few studies have looked at the effects of PACs in vivo, and
whether or not they are able to reach their target tissue intact.
The effect of CPACs on GI health was systematically evaluated
using different in vitro models. CPACs were found to reduce
infectivity of two intestinal pathogens, without affecting the
viability of either the bacteria or the host. In addition, CPACs
cause a rearrangement of host cell cytoskeleton, and as a result, are
able to block invasion in a non-specific manner. Because CPACs
are able to act non-specifically and do not affect viability, these
cranberry extracts may offer a potential alternative to antibiotics.
A key advantage over conventional antibiotics is that CPACs do
not pose the risk of antibiotic resistance and could potentially cost
much less than current options. Future studies should evaluate the
use of CPACs in vivo, and their effects on the infection of common
intestinal pathogens.
Materials and Methods
Cranberry proanthocyanidin
Dry PAC extract from the American cranberry species Vaccinium
macrocarpon was isolated and purified as described previously [2].
Dry CPAC powder was solubilized in deionized (DI) water to
obtain a CPAC stock solution of 1.5 mg/mL which was
subsequently filtered with a 0.20 mm syringe filter and stored at
4uC in the dark. Prior to experimentation, CPAC was diluted to
the desired concentration from the stock solution.
Strains, plasmids and growth media
The streptomycin-resistant (Sm
r) EPEC O127:H6 strain
E2348/69 [46] was used for the majority of experimentation.
EPEC-GFP was made by transforming EPEC with the kanamycin
resistant plasmid pAT113-GFP [47]. Rabbit diarrheagenic E. coli
strain 1b (RDEC-1b) was provided by Dr. Jose ´e Harel (Universite ´
de Montre ´al). Three Salmonella enterica serovar Typhimurium (S.
Typhimurium) isolates were also used. Specifically, strains Keller
[48], SL1344 [49] and 14028S (ATCC).
A single colony from an agar plate was used to inoculate 5 mL
of media in a glass culture tube, and incubated overnight at 37uC
and shaking at 220 rpm. For Escherichia coli, lysogeny broth (LB,
5 g yeast extract (EMD Chemicals), 10 g sodium chloride (Fisher)
and 10 g tryptone (EMD) per litre of DI) was used as medium,
while trypticase soy broth (TSB, Becton-Dickinson) was used for
Salmonella. Agar plates were made by adding 15 g agar (Bioshop)
per litre media.
Bacterial growth curves were obtained by diluting an overnight
culture 1:100 into 5 mL fresh media containing 0 or 100 mg/mL
CPAC and incubating at 37uC and 220 rpm. A sample was
removed every two hours and measurements were obtained by
reading the optical density at 600 nm.
Cell culture
All cells were maintained at 37uC and 5% CO2 in a humidified
incubator in high glucose Dulbecco’s Modified Eagle Medium
(DMEM, Invitrogen) with 10% heat-inactivated foetal bovine
serum (iFBS, Thermo Scientific). HeLa cells (ATCC CCL-2) were
passaged 1:10 once 60–90% confluency was reached using 0.25%
Trypsin with EDTA (Invitrogen) and incubating for 3 minutes.
J774 murine macrophage (ATCC TIB-67) cells were harvested
and passaged at 1:10 as needed. Macrophage cells were passaged
by replacing used media, scraping cells into fresh media,
centrifuging for 3 minutes at 500 g and adding resuspended cells
to a new flask. Passage numbers between 5 and 25 were used for
experiments involving the different cells.
Pedestal assay
Assessment of pedestal formation was performed as previously
described [50]. Briefly, 24 hours prior to infection, HeLa cells
were plated at a density of 2610
5 cells per well in a 24-well plate
(Costar) containing sterile round glass coverslips and incubated at
37uC and 5% CO2. An overnight culture of EPEC-GFP was
diluted to a multiplicity of infection (MOI) of 50 into serum-free
DMEM containing no CPAC (control) or 100 mg/mL CPAC and
incubated for 1 hour at 37uC and 5% CO2. Media in the 24-well
plates was then replaced with the prewarmed media containing
bacteria, and plates were incubated for 6 hours at 37uC and 5%
CO2. Cells were then washed three times with phosphate buffered
saline (PBS) containing 100 mM calcium and 100 mM magne-
sium to remove non-adhered free-floating bacteria. Cells were
fixed with 2.5% paraformaldehyde (PFA, Canemco) for 15 min-
utes at room temperature.
Following fixation, cells were permeabilized and blocked with
0.1% Triton X-100 (BioShop)/10% normal goat serum (NGS,
Invitrogen) in PBS for 30 minutes at room temperature. Actin was
stained with Alexa 568-conjugated phalloidin (Invitrogen) diluted
1:100 into 0.1% Triton X-100/10% NGS in PBS. Following this,
cells were washed three times with PBS and once with DI before
being mounted using ProLong Gold Anti-fade Reagent (Invitro-
gen) and curing overnight.
Images were acquired using a Carl Zeiss Laser Scanning
Microscope (LSM) 5 Exciter with Argon laser at 488 nm (green)
and Helium-Neon laser at 543 nm (red). Emission light was split to
allow Channel 1 (red) to receive wavelengths above 560 nm and
Channel 2 to receive wavelengths between 505–530 nm. Of each
sample, three images were taken, containing a Z-stack of 25 slices
each for a thickness of about 7 mm. Images were Z-projected using
ImageJ and representative images were selected for Figure 1. For
the purposes of bacterial enumeration, the green image was
analyzed further. Threshold values were set to represent bacteria
in black and background in white and software measurement tools
calculated the percentage of bacterial coverage.
Gentamycin protection assay
Using 24-well plates, HeLa cells were set out at a density of
2610
5 cells/mL in 500 ml DMEM+10% iFCS. S. Typhimurium
cells were grown overnight and then diluted 1:15 in fresh TSB
media containing 0, 25, 50 or 100 mg/mL CPAC. After 1.5 hours
of incubation at 37uC and 220 rpm, the bacterial suspension was
adjusted to an optical density of 0.9 (600 nm) and further diluted
1:100 into fresh DMEM containing the target concentration of
CPAC. This medium was used to replace the HeLa cell medium
and plates were centrifuged at 500 g for 5 minutes to promote
bacterial contact with host cells. Following a 40 minute incubation
period at 37uC and 5% CO2, wells were washed with PBS, and
DMEM containing 100 mg/mL gentamycin (Invitrogen) was
Cranberry Proanthocyanidins and Enteric Infections
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were lysed with 1% Triton X-100. Wells were serially diluted,
plated onto agar plates, and enumerated manually.
For imaging, HeLa cells were plated in 24-well dishes
containing sterile glass coverslips as described above. Following
infection, cells were washed and fixed as described above. Inside-
outside staining was performed by using unconjugated rabbit anti-
Salmonella as primary antibody (Cedar Lane, diluted 1:100) and
Alexa-Fluor 488 or 568 (diluted 1:100) goat anti-rabbit IgG as
secondary antibodies. Cells were treated with primary antibody for
1 hour, washed three times with PBS and then treated with an
Alexa 488-conjugated secondary antibody for 30 minutes. Fol-
lowing three more washes with PBS, cells were permeabilized with
0.1% Triton X-100/10% NGS in PBS for 15 minutes and
staining was repeated but using an Alexa 568-conjugated
secondary antibody. Cells were treated with DAPI (49,6-diami-
dino-2-phenylindole, Sigma), diluted 1:100 for 5 minutes and
mounted using ProLong Gold.
Imaging was performed on a Zeiss Axiovert fluorescent
microscope equipped with an apotome. Twelve Z-slices totalling
3 mm thick were obtained for each image, and a minimum of 5
images were taken per slide. Z-projections were prepared using
ImageJ. The red image was subtracted from the green image using
ImageJ and the subsequent RGB image is obtained. External
bacteria are thus shown in green whereas internal bacteria are
shown in red. Representative images were taken from one of four
experimental repeats.
Secretion assay
EPEC from an overnight culture was diluted 1:50 into serum-
free DMEM containing 0, 25, 50 and 100 mg/mL CPAC and
incubated at 37uC and 5% CO2. After 4 hours, secreted proteins
were separated from whole cells by 5 minutes centrifugation at
16 0006g. Proteins pellets were collected in 160 mL sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
loading buffer before resolution by 12% SDS-PAGE for 1.5 hours
and 100 V. A western blot was used to visualize the effect of
CPAC on type-III secreted protein Tir. Briefly, proteins were
transferred onto PVDF membrane and blocked with 5% (w/v)
milk in TBST overnight at 4uC. Primary antibody, mouse anti-Tir
was diluted 1:5000 in TBST+5% milk and incubated for 2 hours
before washing and using anti-mouse conjugated HRP diluted
1:5000 for an additional 2 hours. Western blot was exposed to film
for 10 seconds before developing.
Additionally, EPEC secreted proteins were collected and
incubated with 0, 25, 50, 100 mg/mL CPAC for 30 min and
220 rpm. Samples were centrifuged for 5 min at 16 0006g.
Proteins in pellet were collected with SDS-loading buffer. Proteins
in supernatant were precipitated by 10% (v/v) trichloroacetic acid
for 1 hour at 4uC and collected with SDS-loading buffer after
centrifugation at 16 0006g for 20 minutes and 4uC before
running on 12% SDS-PAGE.
Cytoskeletal protein visualization
HeLa cells were set out on glass coverslips in 24-well plates as
described above. After 24 hours of incubation, media was replaced
to contain 0, 25, 50 or 100 mg/mL CPAC in serum-free DMEM
and further incubated for 4 hours at 37uC and 5% CO2. A variety
of cytoskeletal antibodies were used to examine the effect of
CPAC. Mouse anti-vasodilator-simulated phosphoprotein (VASP),
mouse anti-a-actinin and mouse anti-paxillin were diluted 1:100
and used as primary antibodies for immunofluorescence. After
fixing, blocking and permeabilizing (as described above), cells were
incubated for 1 hour with primary antibody. Cells were washed
and incubated with Alexa-Fluor 488 conjugated goat anti-mouse
IgG, Alexa 568-conjugated phalloidin and DAPI diluted 1:100 for
30 minutes at room temperature. Samples were washed and
mounted as described above. Images were acquired using a Zeiss
Axiovert fluorescence microscope with apotome. Five images were
taken of each sample at 636magnification. Representative images
of VASP protein were included in the figure. Similar effects were
observed for the other cytoskeletal proteins examined (data not
shown).
Mammalian cell viability/cytotoxicity
HeLa cells were set out on glass coverslips in 24-well plates as
described above. After 24 hours of incubation, media was replaced
to contain 0, 25, 50, 100 or 200 mg/mL CPAC in serum-free
DMEM and further incubated for 4 hours at 37uC and 5% CO2.
Cells were washed three times and viability was assessed using a
Live/Dead Viability/Cytotoxicity kit for mammalian cells (Invi-
trogen). A solution of 2 mM calcein AM and 4 mM ethidium
homodimer-1 was used for 45 minutes to stain live cells green and
dead cells red. Imaging was performed directly after staining using
a Zeiss Axiovert fluorescence microscope at 46magnification. A
minimum of six images were acquired at each concentration of
CPAC. Red images were analyzed to obtain the percent coverage
of dead cells using ImageJ.
BioParticle assay
Murine macrophage cells were set out at a density of 1610
6
cells/mL in clear-bottomed black 96-well plates (Costar) and
allowed to settle for 1.5 hours at 37uC and 5% CO2. pHrodo E.
coli BioParticles were purchased from Invitrogen and prepared
according to manufacturer recommendations. CPAC was added
to BioParticles to 0, 50 and 100 mg/mL. Cell culture media was
replaced with BioParticle suspension containing the various
concentrations of CPAC and incubated for 3 hours at 37uC.
BioParticles are conjugated to a fluorogenic dye that dramatically
increases in fluorescence as the surrounding pH becomes more
acidic; namely, when the BioParticle becomes internalized by
macrophage cells. Wells were read using fluorescent plate reader
(Synergy MX) at an excitation and emission of 560/585 mn.
Fluorescence values from control wells containing BioParticles but
no cells were subtracted from the values of those containing cells.
Supporting Information
Figure S1 RDEC-1b pedestal formation in the presence of
CPAC. HeLa cells were infected for 6 hours with Rabbit
Diarrheagenic E. coli strain 1 (RDEC-1b; kindly provided by Dr.
Jose ´e Harel, Universite de Montreal) in the presence or absence of
100 mg/mL CPACs, then fixed and stained as described in the
materials and methods section. Left panels are RDEC stained with
rabbit-anti-E. coli antibody (Thermo Scientific), centre panels are
Alexa-568 phalloidin staining and colour overlays are shown on
the right (E. coli in green and phalloidin staining in red). Control
experiment (top panels) demonstrates the presence of striking actin
recruitment beneath adherent bacteria (e.g. near arrowhead). In
the presence of 100 mg/mL CPACs (bottom panels), localization
of actin beneath RDEC bacteria was greatly diminished (e.g. near
arrowhead) and the number of adherent bacteria was reduced.
(JPG)
Figure S2 Invasion of HeLa cells by Salmonella Typhimurium. S.
Typhimurium strains SL1344 and 14028S were grown overnight
and seeded 1:15 in fresh TSB media containing 0, 25, 50 or
100 mg/mL CPAC. After 1.5 hours of incubation at 37uC and
220 rpm, the bacterial suspension was adjusted to an optical
Cranberry Proanthocyanidins and Enteric Infections
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27267density of 0.9 (600 nm) and further diluted 1:100 into fresh serum-
free DMEM containing the target concentration of CPAC. This
medium was used to replace medium in wells, and plates were
centrifuged at 500 g for 5 minutes. HeLa cells were infected with
both S. Typhimurium strains for 40 minutes, and internalized
bacteria were enumerated manually by direct plate counting. S.
Typhimurium readily invades cells when no CPAC is present at a
frequency of about 1 bacterium per 10 HeLa cells. In the presence
of 25 mg/mL CPAC, this frequency is diminished roughly 100%.
Near negligible amounts of bacteria were found to have invaded at
CPAC concentrations of 50 and 100 mg/mL. Error bars on graph
represent one standard deviation.
(TIF)
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